Post-Traumatic Stress Disorder (PTSD)
Use of HIRREM, a closed-loop, allostatic, acoustic, stimulation neurotechnology can reduce PTSD symptoms, insomnia and depression in veterans.
CPAP therapy shows to reduce PTSD symptoms in veterans with PTSD and OSA.
Treatment with psychotropic medications may influence dementia risk in veterans with posttraumatic stress disorder.
Posttraumatic stress disorder is associated with a high incidence of chronic pain; what role headache plays in that relationship is not well known.
Veterans with comorbid PTSD and dementia were more likely to be prescribed second-generation antipsychotics.
Prior research has speculated that PTSD may be caused in part by an underlying REM sleep dysfunction that is amplified by OSA.
Veterans with epilepsy could benefit from evidence-based chronic disease self-management programs that target physical and psychiatric comorbidities.
The PTSD group had changes suggestive of decreased local and global network efficiency.
About one-fifth of responders to 9/11 developed PTSD.
Patients who continue to experience symptoms for a year or longer may not benefit from current therapies.
A decline in quality of life during hospitalization predicts 6-month outcomes.
Veterans randomized to mindfulness-based stress reduction reported greater reductions in pain, fatigue, and memory/concentration problems.
Combat veterans face an elevated risk of developing PTSD and comorbid depression, which severely affects quality of life.
Those with PTSD showed decreased path length and increased clustering coefficient, global efficiency, and local efficiency.
The polymer-based material changes color based on the force of impact.
Case study shows sustained remission from symptoms of aggression, emotional dysregulation in child with PTSD.
Patients experienced improvements in irritability, depression, and quality of life.
Symptoms may become more severe as neurological health declines with age.
SPECT detected the subtle functional and structural changes in the brain between those with PTSD, TBI, or both.
Researchers results found a 60% greater risk of CVD in women with severe PTSD
Traumatic brain injury increases unemployment rates in veterans but does not affect divorce rates.
Researcher suggest screening veterans with PTSD for sleep apnea.
The findings suggest that PTSD should be considered a full systemic disorder rather than a mental illness.
While symptoms improved equally in both groups, patients that received a second SGB injection saw even greater improvement.
Researchers are now focusing on finding out what triggers the interferon signal prior to PTSD development.
Curcumin, a substance found in turmeric powder, may help reduce damage from Alzheimer's and ease symptoms of PTSD.
Both parents and children exhibited criteria of PTSD and significant levels of anxiety.
The effects of prolonged exposure therapy and eye movement desensitization and reprocessing therapy were maintained at six month follow-up.
Researchers found that messenger chemical BDNF activated neurons in the amygdala where the memory is stored.
Researchers will explore the role of microRNA in the preservation of memories.
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Reduced Risk for Multiple Sclerosis Linked to Greater Sun Exposure
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- FDA Approves Blood Test to Assess Concussion
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Incidence of Delayed Traumatic Intracranial Hemorrhage Low in Older Adults With Blunt Head Trauma
- Older Epilepsy Patients More Likely to Experience AED, Non-AED Drug Interaction
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Accelerated Cognitive Decline Associated With Retinopathy
- Treatment Effects Often Exaggerated in Early Clinical Studies